Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating common nail problems

R Sinclair1

  • 1Skin and Cancer Foundation, Alfred Hospital, East Melbourne.

Australian Family Physician
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

This article reviews current nail condition management options, building on previous diagnostic insights. It addresses challenging nail problems and their effective treatment strategies for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Long-term efficacy and safety of baricitinib in patients with severe alopecia areata: 104-week results from BRAVE-AA1 and BRAVE-AA2.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data.

The Australasian journal of dermatology·2023
Same author

Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Alopecia areata: progress, but who pays?

The British journal of dermatology·2021
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Area of Science:

  • Dermatology
  • Nail Medicine

Background:

  • Nail conditions frequently present diagnostic and management challenges.
  • Previous literature addressed initial diagnostic issues.
  • This article focuses on the subsequent management phase.

Purpose of the Study:

  • To outline current management strategies for complex nail conditions.
  • To provide an update on therapeutic options for nail disorders.

Main Methods:

  • Review of current medical literature on nail condition management.
  • Synthesis of established and emerging treatment protocols.

Main Results:

  • Discussion of various therapeutic modalities for diverse nail pathologies.
  • Highlighting effective approaches for difficult-to-manage nail diseases.

Related Experiment Videos

Conclusions:

  • Current management options offer improved strategies for challenging nail conditions.
  • Effective treatment requires a thorough understanding of available therapeutic choices.